GEMTUZUMAB OZOGAMİSİN(GO) PROTOKOLÜ

Kaynaklar:

1- Döhner H, Estey EH, Amadori S, et al. . Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 2010;115:453–74.

2- Thol F, Schlenk RF. Gemtuzumab ozogamicin in acute myeloid leukemia revisited. Expert Opin Biol Ther 2014;14:1185–95

3- Estey EH, Giles FJ, Beran M, et al. . Experience with gemtuzumab ozogamycin ("mylotarg") and all-trans retinoic acid in untreated acute promyelocytic leukemia. Blood 2002;99:4222–4

4- Castaigne S, Pautas C, Terré C, et al. . Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study. Lancet 2012;379:1508–16.

5- Kharfan-Dabaja MA, Hamadani M, Reljic T, et al. . Gemtuzumab ozogamicin for treatment of newly diagnosed acute myeloid leukaemia: a systematic review and meta-analysis. Br J Haematol 2013;163:315–25.